Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ISRCTN25163383) titled 'A phase 1 open-label study to assess the safety and PK of novel CBD soft-gel capsule' on Aug. 22.
Study Type: Interventional
Study Design:
Interventional randomized crossover controlled trial (Safety, Efficacy)
Primary Sponsor: Clerkenwell Health
Condition:
Healthy volunteers. Intended indication is Clinical High Risk for Psychosis (CHR-P).
Mental and Behavioural Disorders
Intervention:
Fourteen participants will be enrolled into the study (to provide a minimum of 12 evaluable participants).
Participants will receive the following dose regimens in a randomised order across 3 treatment periods:
* Regimen A...